PT-141 (Bremelanotide) – 10mg

$43.00

Quantity discounts
Quantity Discount Price
4-63%$41.71
7-96%$40.42
10-Unlimited9%$39.13
Quantity discounts
Quantity Discount Price
4-63%$41.71
7-96%$40.42
10-Unlimited9%$39.13
Sale 9%
PT-141 (Bremelanotide) – 10mg $43.00

PT-141 (Bremelanotide) – 10mg is a synthetic peptide studied for its potential in treating sexual dysfunction, enhancing libido, and promoting vascular health.

Sale 9%
Bacteriostatic Water – 10ml $7.00

Bacteriostatic Water – 10ml is a sterile, multi-use diluent designed for research purposes, commonly used to reconstitute peptides and compounds in laboratory settings.

Sale 9%
Ipamorelin – 5mg $43.00

Ipamorelin – 5mg is a research peptide studied for its role in stimulating growth hormone release, promoting muscle growth, enhancing recovery, and supporting anti-aging research.

Sale 9%
Melanotan 2 (MT-II) – 10mg $45.00

Melanotan 2 (MT-II) – 10mg is a synthetic peptide studied for its effects on skin tanning, appetite regulation, sexual function, and inflammation.

Sale 9%
Semax – 10mg $35.00

Semax – 10mg is a synthetic peptide known for its neuroprotective and nootropic properties. Research focuses on its role in cognitive enhancement, stroke recovery, and mood regulation.

              
Total: $173.00








PT-141 (Bremelanotide) – 10mg | Research Peptide for Sexual Function


PT-141 (Bremelanotide) – 10mg

PT-141 (Bremelanotide) – 10mg is a synthetic peptide developed for research into sexual dysfunction, libido enhancement, and vascular health. Acting directly on the central nervous system (CNS) through melanocortin receptors, PT-141 is unique among sexual health peptides for its dual focus on psychological and physical aspects of sexual function.

Chemical Information

  • Chemical Formula: C₅₀H₆₈N₁₄O₁₀
  • Molecular Mass: 1025.2 g/mol
  • Synonyms: Bremelanotide, PT-141
  • CAS Number: 189691-06-3
  • PubChem ID: 9941375
  • Total Amount: 10 mg
  • Shelf Life: 2 years when stored at -20°C

What is PT-141 (Bremelanotide)?

PT-141 is a synthetic peptide derived from Melanotan II, initially researched for its effects on melanogenesis. Its discovery as a melanocortin receptor agonist led to a new focus on its role in enhancing sexual arousal and treating dysfunction in both men and women. Unlike traditional erectile dysfunction treatments, PT-141 targets the brain to improve sexual desire and performance.

Research Benefits of PT-141 – 10mg

1. Treatment of Erectile Dysfunction (ED)

PT-141 stimulates neural pathways to promote sexual arousal and erections in men, making it effective even for those unresponsive to PDE-5 inhibitors like sildenafil [1].

2. Treatment of Female Sexual Arousal Disorder (FSAD)

Research highlights PT-141’s potential in treating FSAD by activating brain pathways that enhance libido and sexual satisfaction in women [2].

3. Improved Sexual Desire and Libido

By targeting central pathways associated with sexual function, PT-141 is studied for its potential to enhance motivation and arousal in experimental models [3].

4. Non-Hormonal Mechanism for Sexual Dysfunction

PT-141 provides a non-hormonal alternative for treating conditions like hypoactive sexual desire disorder (HSDD) and erectile dysfunction in individuals with hormonal imbalances [4].

5. Potential Use in Sexual Disorders Related to Stress and Anxiety

By acting on the CNS, PT-141 may address psychological barriers to arousal, such as performance anxiety and stress-induced dysfunction [5].

6. Enhanced Blood Flow and Vascular Health

PT-141 is studied for its potential to support vascular health by modulating nitric oxide pathways, which may improve circulation and support blood flow in experimental models [6].

Warning: This product is for laboratory research purposes only. Not for human or animal use.

Scientific References

  1. Wessells, H., et al. “Melanocortin Receptor Agonists and Erectile Function: PT-141 in the Treatment of Erectile Dysfunction.” International Journal of Impotence Research, vol. 16, no. 2, 2004, pp. 70-75.
  2. Kingsberg, S.A., et al. “Bremelanotide for Female Sexual Dysfunction: A Randomized Placebo-Controlled Trial.” Obstetrics & Gynecology, vol. 132, no. 5, 2018, pp. 1188-1196.
  3. Diamond, L.E., et al. “Efficacy and Safety of Bremelanotide for Hypoactive Sexual Desire Disorder in Women.” Journal of Sexual Medicine, vol. 13, no. 2, 2016, pp. 191-200.
  4. Safarinejad, M.R. “Bremelanotide: A Novel Treatment for Male and Female Sexual Dysfunction.” Drugs of Today, vol. 44, no. 1, 2008, pp. 27-36.
  5. Pfaus, J.G., et al. “Central Mechanisms of Sexual Arousal: The Role of Melanocortin Pathways.” Journal of Sexual Medicine, vol. 6, no. 2, 2009, pp. 70-84.
  6. Molinoff, P.B., et al. “Bremelanotide and Nitric Oxide: Mechanisms of Action in Erectile Dysfunction.” Clinical Pharmacology & Therapeutics, vol. 85, no. 1, 2009, pp. 11-17.


Based on 0 reviews

0.00 Overall
0%
0%
0%
0%
0%
Be the first to review “PT-141 (Bremelanotide) – 10mg”

Your email address will not be published. Required fields are marked *

Reviews

There are no reviews yet.

My Cart
Recently Viewed
Compare Products (0 Products)
Compare Product
Compare Product
Compare Product
Compare Product
Categories